SLC5A2 and type 2 diabetes mellitus: Furthermore, the effects of DPP‐4 inhibitors on renal function in clinical practice are not well established.26, 27 The present study, therefore, offered us an opportunity to explore the effects of SGLT2 inhibitors and DPP‐4 inhibitors on renal function in patients with type 2 diabetes.